Please assess the completion status of the following clinical trial:

Trial Title: Chemotherapy and Radiotherapy for Osteolymphoma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed non-Hodgkin's lymphoma in a bony site~* Limited extraosseous disease~* Ann Arbor stage IE~* Age \>17~* ECOG performance status \<3~* Expected survival \> 6 months~* Patients capable of childbearing are using adequate contraception.~* Written informed consent~Exclusion Criteria:~* Previous radiotherapy~* Previous malignancy~* Medically unfit to undergo treatment

- Gender: ALL
- Minimum Age: 17 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Chemotherapy followed by radiotherapy to begin 3 weeks after the last cycle.

Based on this trial design, predict the completion outcome and termination type (if applicable).